<code id='C818E6A664'></code><style id='C818E6A664'></style>
    • <acronym id='C818E6A664'></acronym>
      <center id='C818E6A664'><center id='C818E6A664'><tfoot id='C818E6A664'></tfoot></center><abbr id='C818E6A664'><dir id='C818E6A664'><tfoot id='C818E6A664'></tfoot><noframes id='C818E6A664'>

    • <optgroup id='C818E6A664'><strike id='C818E6A664'><sup id='C818E6A664'></sup></strike><code id='C818E6A664'></code></optgroup>
        1. <b id='C818E6A664'><label id='C818E6A664'><select id='C818E6A664'><dt id='C818E6A664'><span id='C818E6A664'></span></dt></select></label></b><u id='C818E6A664'></u>
          <i id='C818E6A664'><strike id='C818E6A664'><tt id='C818E6A664'><pre id='C818E6A664'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:593
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Lack of health data on LGBTQ+ people has serious consequences
          Lack of health data on LGBTQ+ people has serious consequences

          FrankFranklinII/APLackofhealthdataonLGBTQ+peoplehasreal-worldconsequences.Aparticipantina2020reportf

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

          AdobeSomeofthecountry’sbiggesthealthinsurerssaidTuesdaythatuptoone-quarteroftheirclaimsarerunthrough